Upcoming Events


Past Events

Dec 1, 2022 at 10:30 AM EST
5th Annual Evercore ISI HealthCONx Conference
Nov 29, 2022 at 7:50 PM EST
Clarity AD: Lecanemab Phase 3 Data Presentation Webcast at CTAD
Sep 12, 2022 at 9:55 AM EDT
Biogen at the Morgan Stanley 20th Annual Global Healthcare Conference
Mar 7, 2022 at 9:50 AM EST
Biogen at the Cowen 42nd Annual Health Care Conference
Nov 11, 2021 at 5:10 PM EST
Dose and time dependent changes in plasma ptau181 in patients treated with aducanumab in the ENGAGE and EMERGE trials at CTAD
Nov 9, 2021 at 8:00 AM EST
Baseline EMBARK data from EMERGE, ENGAGE, and PRIME participants in the EMBARK re-dosing study at CTAD
Mar 13, 2021
Evaluation of aducanumab efficacy and safety in early Alzheimer’s disease Discussion at AD/PD
Mar 10, 2021
Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE Discussion at AD/PD
Nov 30, 2020 at 9:00 AM EST
Biogen and Sage Collaboration Webcast
Sep 23, 2020
Aducanumab Phase 3 Topline Results at the AAN 2020 Science Highlights (encore virtual presentation replay)
Sep 19, 2020
Aducanumab Phase 3 Topline Results at the 23rd Chinese National Conference of Neurology (encore virtual presentation replay)
May 11, 2020
Biogen at the 2020 World Medical Innovation Forum (replay)